SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Research and Competitive Product Differentiation in the Pharmaceutical Industry in the United States
0 references·7 citing·31 second hop
Research and Competitive Product Differentiation in the Pharmaceutical Industry in the United States (1964)Research and Competitive Product Differen…Assessing the Impact of Field-of-Use Restrictions in Patent Licensing Agreements: The Ethical Pharmaceutical Industry in the United States, 1950–1962 (2017)Assessing the Impact of Field…Towards a sustainable system of drug development (2014)Towards a sustainable system …Before Bayh-Dole: public research funding, patents, and pharmaceutical innovation (1945-1965) (2011)Before Bayh-Dole: public rese…Choosing the Competition and Patent Licensing (1990)Choosing the Competition and …The Rate of Obsolescence of Technical Knowledge--A Note (1978)The Rate of Obsolescence of T…Price and Quality Competition in the United States Drug Industry (1978)Price and Quality Competition…Patent Statistics as a Measure of Technical Change (1969)Patent Statistics as a Measur…From Entry Barriers to Mobility Barriers: Conjectural Decisions and Contrived Deterrence to New Competition* (1977)The Role of Investment in Entry-Deterrence (1980)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1993)Licensing the market for technology (2003)The licensing dilemma: understanding the determinants of the rate of technology licensing (2006)The Market for Patents in Europe (2006)Price Discrimination in Medicine (1958)The Economics of Information (1976)Pharmaceutical Policies in OECD Countries (2000)The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis (2002)Invention and Economic Growth (1966)Invention, Growth and Welfare: A Theoretical Treatment of Technological Change. (1970)Knowledge Acquisition via Three Learning Processes in Enterprise Information Portals: Learning-By-Investment, Learning-by-Doing, and Learning-from-Others1 (2005)Knowledge Recombination Across Technological Boundaries: Scientists vs. Engineers (2012)The Economics of Industrial Innovation (2012)Dynamics of imitation versus innovation in technological leadership change: Latecomers’ catch-up strategies in diverse technological regimes (2024)Some Difficulties in Measuring Inventive Activity (1962)Corporate Inventive Output, Profits, and Growth (1965)The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry (1999)Collaboration Networks, Structural Holes, and Innovation: A Longitudinal Study (2000)Technological acquisitions and the innovation performance of acquiring firms: a longitudinal study (2001)Can the pharmaceutical industry reduce attrition rates? (2004)Lessons from 60 years of pharmaceutical innovation (2009)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Making individualized drugs a reality (2017)How expected outcomes, stakeholders, and institutions influence corporate social responsibility at different levels of large basic needs firms (2018)Patents and Innovation: An Empirical Study (1986)Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research (1996)Why Did Universities Start Patenting? (2008)Economic Welfare and the Allocation of Resources for Invention (1962)Appropriating the Returns from Industrial Research and Development (1987)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1969Patent Statistics as a Measure of Technical Change346 cited
  • 1990Choosing the Competition and Patent Licensing229 cited
  • 1978Price and Quality Competition in the United States Drug Industry64 cited
  • 1978The Rate of Obsolescence of Technical Knowledge--A Note61 cited
  • 2014Towards a sustainable system of drug development58 cited
  • 2011Before Bayh-Dole: public research funding, patents, and pharmaceutical innovation (1945-1965)6 cited
  • 2017Assessing the Impact of Field-of-Use Restrictions in Patent Licensing Agreements: The Ethical Pharmaceutical Industry in the United States, 1950–19625 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work